Analysts at HC Wainwright lowered their FY2024 earnings estimates for shares of MediWound in a report released on Wednesday, ...

HC Wainwright reiterated their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a research report sent to ...

CleanSpark Inc (NASDAQ:CLSK) shares were down on Tuesday, even after the company reported upbeat fourth-quarter results. The ...

Q4 2024 Earnings Call Transcript December 2, 2024 CleanSpark, Inc. misses on earnings expectations. Reported EPS is $-0.27 ...

Although it has lowered in recent days, commentators were mostly positive, with one hold and four buy recommendations on the stock. The consensus rating for the stock, as classified by MarketBeat, is ...

Wall Street expects Bitcoin miner CleanSpark Inc (NASDAQ:CLSK) to report a loss of 18 cents per share and $88.65 million in ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $28.0 to $50.0 for TG Therapeutics over the last 3 months. Looking at ...

On Friday, H.C. Wainwright maintained a Neutral rating and a $7.00 price target on Agenus Inc . (NASDAQ:AGEN), a biotechnology company currently valued at approximately $82 million. According to ...

Reiterates HC Wainwright & Co.: Neutral to Neutral 11/11/2024 Maintains HC Wainwright & Co.: Neutral to Neutral 8/12/2024 Reiterates HC Wainwright & Co.: Neutral to Neutral 6/17/2024 Maintains HC ...

as recommended by H.C. Wainwright. According to InvestingPro analysis, the stock appears undervalued at its current trading level. The reaffirmation came after IceCure Medical announced its third ...

H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares following the Q3 report. The business stalled until new funding ...

H.C. Wainwright maintains a Buy rating and 12-month price target of $11 on CollPlant (CLGN) shares after the company reported Q3 results and provided a corporate update on November 27. The firm ...